Literature DB >> 25024670

Comparison of 3 body size descriptors in critically ill obese children and adolescents: implications for medication dosing.

Emma L Ross1, Jennifer Jorgensen1, Peter E DeWitt2, Carol Okada3, Renee Porter4, Matthew Haemer4, Pamela D Reiter1.   

Abstract

OBJECTIVE: To compare 3 methods of weight determination for medication dose calculations in obese children and to discuss feasibility for use in routine care.
METHODS: This was a patient safety and quality improvement study evaluating patients (2-19 years old) admitted to the pediatric intensive care unit during a 13-month period (July 2010-July 2011). Patients identified as obese (≥95th percentile body mass index [BMI] for age), including severely obese (≥99th percentile BMI for age), were included in the weight method comparison portion of this study. Lean body mass estimations, using equations derived by the Peters and Foster methods, were compared to ideal body weight estimates by using the BMI method. Absolute differences between values generated by the 3 methods, intraclass correlation (ICC), and Bland-Altman plots were calculated.
RESULTS: A total of 1369 patients met initial criteria; 176 met criteria for the dosing weight comparison (age ± SD = 9.28 ± 5 years; actual weight ± SD = 55.5 ± 33.9 kg; 46% female). Sixty were severely obese and 116 were obese. Mean ICC between methods was 0.968 (95% Confidence interval (CI): 0.959, 0.975). The Peters method estimated higher weights than the Foster or BMI method. Bland-Altman plots illustrated good agreement between methods in children with weight below 50 kg, but decreased agreement above 50 kg, which was influenced by sex.
CONCLUSIONS: All methods demonstrated strong correlation and acceptable agreement in children below 50 kg. Systematic biases were identified in children above 50 kg where variance was higher. The BMI method was least complex to calculate and the most feasible method for daily use.

Entities:  

Keywords:  body mass index; ideal body weight; lean body mass; obesity; pediatric

Year:  2014        PMID: 25024670      PMCID: PMC4093662          DOI: 10.5863/1551-6776-19.2.103

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  21 in total

1.  Evaluation of body fat in fatter and leaner 10-y-old African American and white children: the Baton Rouge Children's Study.

Authors:  G A Bray; J P DeLany; D W Harsha; J Volaufova; C C Champagne
Journal:  Am J Clin Nutr       Date:  2001-04       Impact factor: 7.045

2.  Relation of BMI to fat and fat-free mass among children and adolescents.

Authors:  D S Freedman; J Wang; L M Maynard; J C Thornton; Z Mei; R N Pierson; W H Dietz; M Horlick
Journal:  Int J Obes (Lond)       Date:  2005-01       Impact factor: 5.095

Review 3.  The relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007.

Authors:  Sarah C McLeay; Glynn A Morrish; Carl M J Kirkpatrick; Bruce Green
Journal:  Clin Pharmacokinet       Date:  2012-05-01       Impact factor: 6.447

4.  Bone mineral and body composition measurements: cross-calibration of pencil-beam and fan-beam dual-energy X-ray absorptiometers.

Authors:  K J Ellis; R J Shypailo
Journal:  J Bone Miner Res       Date:  1998-10       Impact factor: 6.741

5.  Pharmacokinetics and drug dosing in obese children.

Authors:  Jennifer G Kendrick; Roxane R Carr; Mary H H Ensom
Journal:  J Pediatr Pharmacol Ther       Date:  2010-04

6.  Development and validation of a predictive equation for lean body mass in children and adolescents.

Authors:  Bethany J Foster; Robert W Platt; Babette S Zemel
Journal:  Ann Hum Biol       Date:  2012-05       Impact factor: 1.533

Review 7.  Dosing dilemmas in obese children.

Authors:  H Mulla; T N Johnson
Journal:  Arch Dis Child Educ Pract Ed       Date:  2010-06-28       Impact factor: 1.309

8.  Body fat percentages measured by dual-energy X-ray absorptiometry corresponding to recently recommended body mass index cutoffs for overweight and obesity in children and adolescents aged 3-18 y.

Authors:  Rachael W Taylor; Ianthe E Jones; Sheila M Williams; Ailsa Goulding
Journal:  Am J Clin Nutr       Date:  2002-12       Impact factor: 7.045

Review 9.  What is the best size descriptor to use for pharmacokinetic studies in the obese?

Authors:  Bruce Green; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

10.  DXA: can it be used as a criterion reference for body fat measurements in children?

Authors:  Roman J Shypailo; Nancy F Butte; Kenneth J Ellis
Journal:  Obesity (Silver Spring)       Date:  2008-02       Impact factor: 5.002

View more
  4 in total

1.  Medication Dosage in Overweight and Obese Children.

Authors:  Kelly L Matson; Evan R Horton; Amanda C Capino
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Jan-Feb

Review 2.  Drug Dose Selection in Pediatric Obesity: Available Information for the Most Commonly Prescribed Drugs to Children.

Authors:  Kathryn E Kyler; Jonathan Wagner; Chelsea Hosey-Cojocari; Kevin Watt; Valentina Shakhnovich
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

3.  Normalization of glomerular filtration rate in obese children.

Authors:  Liane Correia-Costa; Franz Schaefer; Alberto Caldas Afonso; Manuela Bustorff; João Tiago Guimarães; António Guerra; Henrique Barros; Ana Azevedo
Journal:  Pediatr Nephrol       Date:  2016-03-23       Impact factor: 3.714

4.  Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation.

Authors:  Kelong Han; Thomas Peyret; Angelica Quartino; Nathalie H Gosselin; Sridharan Gururangan; Michela Casanova; Johannes H M Merks; Maura Massimino; Jacques Grill; Najat C Daw; Fariba Navid; Jin Jin; David E Allison
Journal:  Br J Clin Pharmacol       Date:  2015-12-10       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.